In contrast, the expression of 4EBP1 exhibits a decreasing tendency as the pathological stage promoting in two digestive system tumors, namely colon adenocarcinoma (COAD) and stomach adenocarcinoma (STAD) (Figures 1C,J). This evidence concerns the gene EIF4EBP1 and digestive system neoplasm.